Stock Ticker

  • Loading stock data...

The Fast-Track Status of Hemophilia A Drug By Sangamo Therapeutics Inc (NASDAQ:SGMO) Inspires Great Hope, Sources Say

Sangamo Therapeutics Inc (NASDAQ:SGMO) has moved ahead to make an announcement regarding the move to grant fast-track designation to pipeline candidate, SB-525.,something that has sparked high talk among all the concerned parties. According to some top financial officers working with the provider, it has been revealed that Sangamo’s shares declined 145.9% year to date. A […]